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Available online 17 December 2015Type2 diabetes (T2D) is a common,multifactorial disease that is inﬂuenced by genetic and environmental factors
and their interactions. However, common variants identiﬁed by genome wide association studies (GWAS) ex-
plain only about 10% of the total trait variance for T2D and less than 5% of the variance for obesity, indicating
that a large proportion of heritability is still unexplained. The transcriptomic approach described here uses quan-
titative gene expression and disease-related physiological data (deep phenotyping) to measure the direct corre-
lation between the expression of speciﬁc genes and physiological traits. Transcriptomic analysis bridges the gulf
between GWAS and physiological studies. Recent GWAS studies have utilized very large population samples,
numbering in the tens of thousands (or even hundreds of thousands) of individuals, yet establishing causal func-
tional relationships between strongly associated genetic variants and disease remains elusive. In light of the ﬁnd-
ings described below, it is appropriate to consider how and why transcriptomic approaches in small samples
might be capable of identifying complex disease-related genes which are not apparent using GWAS in large
samples.












1.1. The value of transcriptomic analysis in genetic studies
The transcriptome is the complete set of expression products tran-
scribed from the genome in a speciﬁed tissue or population of cells. It
is commonly used to refer to the expression of genome-wide protein
coding genes and we follow that convention here, although our thesis
applies equally to the expression of non-protein coding genes. In this re-
view we discuss the use of whole genome gene expression approaches
(referred to here as transcriptomics) in searching for the genes underly-
ing complex genetic diseases. For brevity and clarity we focus on one
such metabolic disease, type 2 diabetes (T2D), and its effect in Mexican
Americans, as a typical example of a well-studied complex genetic dis-
ease. While we focus on this as a single complex genetic disease, it
should be noted that T2D is strongly correlated with other complex dis-
orders such as obesity, insulin resistance, the metabolic syndrome,nd Obesity Institute (STDOI),
urg Regional Academic Health
SA.
. Jenkinson).
en access article under the CC BY-NCdyslipidemia, cardiovascular disease, and a variety of diabetic complica-
tions. Thus, this discussion has wide relevance to other complex genetic
diseases. It is our contention that transcriptomic approaches can pro-
vide a valuable bridge between the genotype and the phenotype. Recent
studies have highlighted several issues in connecting genotypic
approaches, such as (1) genome-wide association studies (GWAS),
(2) genome-wide sequencing (GWS), and (3) expression quantitative
trait locus (eQTL) analysis, with physiological disease phenotypes. We
propose that the gap between these genotypic approaches and resulting
phenotypes may be bridged or narrowed by the use of transcriptomic
approaches. The reason for this is that transcriptomics occupy a unique
position between the genomic or genotypic level and the physiologic or
phenotypic level. We note that eQTL also provide a potential link
between genotype and phenotype but eQTL typically rely on the con-
nection between genotypes and gene expression and thus may be con-
sidered an enhanced form of GWAS. Gene expression as RNA provides
the direct rawmaterial for protein expression, which acts on andwithin
cells and tissues, inﬂuencing so-called endo-phenotypes, and interme-
diate phenotypes andwhich eventually aremeasurable as physiological
changes at the whole body level
In this review we also address potentially confounding factors such
as the effect of the phenotype, including the disease phenotype, on-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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undergo post-translational modiﬁcation. Nevertheless, these factors do
not seriously affect the underlying rationale. A second issue is that
transcriptomic analysis does not provide a direct causal link between
speciﬁc nucleotides in the genome and downstream phenotypes such
as disease-related clinical traits. This is also a limitation of GWAS and
eQTL studies. However, transcriptomic analysis provides a link between
RNA transcripts, which are copied directly from speciﬁc regions of the
genome, and downstream measurable phenotypes. In this sense they
provide a bridge between genotype and phenotype. Causal evidence re-
quires careful follow-up experiments in model cells, tissues, organisms
and eventually in humans. Transcriptomic experiments provide valu-
able initial correlational evidence to guide these follow-up studies.
2. Background
2.1. The diabetes pandemic and the burden of diabetes in Mexican
Americans
Type 2 diabetes (T2D) is amajor public health issue in theUS, partic-
ularly in minority groups including Mexican Americans, the major sub-
group of the US Hispanic population. Over the past 20 years, we have
examined the genetics of T2D, obesity, metabolic syndrome and their
related traits in low-incomeMexican American families in San Antonio,
Texas. T2D is a complex cardio-metabolic disorder characterized by
both insulin resistance and pancreatic β-cell dysfunction [17] and is as-
sociatedwith signiﬁcantmorbidity from themicro- andmacro-vascular
complications of the disease. The compound burden of an increasing
global T2D epidemic together with its co-morbid conditions including
obesity, dyslipidemia and hypertension makes this a major world-
wide public health problem [3]. The International Diabetes Federation
estimates that globally 382 million people had diabetes in 2013, and
that about 592 million people will be afﬂicted with diabetes by the
year 2035. In the US, according to the Centers for Disease Control and
Prevention [76], it is estimated that approximately 29.1 million people
were afﬂicted with diabetes during the years 2010–2012, of whom
about 21.1 million had diagnosed diabetes, while the remaining 8.1
million were unaware of their disease. The estimated prevalence of
diagnosed diabetes based on age-adjusted data for individuals aged
20 years or older exhibits remarkable ethnic disparities (CDC,
2010–2012): non-Hispanic European Americans = 7.6%, African
Americans = 13.2%, Asians = 9.0%, and Hispanics = 12.8% (of
whom Mexican Americans = 13.9%).
2.2. Genetic variation in T2D and other complex diseases
T2D is a common,multifactorial disease that is inﬂuenced by genetic
and environmental factors and their interactions. There aremany large-
scale ongoing efforts to localize and characterize T2D susceptibility
genes using genome-wide association study (GWAS) approaches. To
date, the GWAS method has achieved substantial success in localizing
novel T2D susceptibility loci and loci for T2D-related glycemic traits
(about 90 loci), obesity loci (~90), and loci for metabolic syndrome or
its components (~50 loci), e.g. reviews: [4,20,28,29,41,47,51,64,65,67].
However, common variants identiﬁed by GWAS explain only about
10% of the total trait variance for T2D [29] and less than 5% of the trait
variance for obesity [4], indicating that a large proportion of trait vari-
ance, and of heritability, is still unexplained [48]. Therefore, there has
been increased interest in the potential role of rare variants in the etiol-
ogy of common complex diseases (rare variant/common disease hy-
pothesis). These rare variants are postulated to have larger penetrance
with potential functional consequences and could contribute tomissing
heritability [13,26,48]. Recent advances in next generation sequencing
(NGS) technologies have made it possible to obtain complete informa-
tion on rare and common variants across the whole exome, genome
or within a targeted region [25] and new information on low frequencyor rare variants, including exome chip based data, that are associated
with T2D is emerging [16,24,45,66,73].
2.3. Functional translation of T2D association signals and the case for deep
phenotyping
A large number of identiﬁed T2D loci has been associated speciﬁcally
with defects in insulin secretion, highlighting the importance of pancre-
aticβ-cell development and dysfunction. Beta cell function is commonly
measured by the oral disposition index and the hyperglycemic clamp,
which measures insulin secretory capacity. In contrast, relatively few
loci have been discovered relating to insulin resistance which is com-
monly assayed by measuring levels of insulin and glucose during the
oral glucose tolerance test (OGTT) and the gold standard euglycemic
hyperinsulinemic clamp. However, recent studies in nondiabetic sub-
jects have focused on loci associatedwith insulin resistance, e.g. reviews
by [29,47,55,68]. Since the overlap between the GWAS association sig-
nals with T2D and fasting glucose is partial, differential genetic inﬂu-
ences on physiological and pathophysiological variation in glucose
homeostasis are possible [29,39]. These localization signals have, so
far, yielded few causal gene identiﬁcations and the functional relevance
of amajority of the implicated genetic variants has yet to be established.
More than 85% of GWAS-identiﬁed variants, including those for T2D, fall
in non-coding regions of the genome, highlighting their potential role in
gene regulation [21,22,34,39]. Efforts to functionally assess GWAS sus-
ceptibility loci are challenging. To enhance our knowledge of biological
mechanisms and translational possibilities corresponding to speciﬁc ge-
netic ﬁndings, the genotype-driven approach, aided with deep pheno-
typing, appears to be a more appealing and powerful strategy [52,69].
Together with more precise characterization of clinical and pathophys-
iologic phenotypes, a range of deep physiological phenotypes (some-
times referred to as “endophenotypes” or intermediate phenotypes)
and “omic-metrics” such as epigenomics, transcriptomics, proteomics
and metabolomics can be examined in an integrated fashion to under-
stand themolecular mechanisms underlying the phenotypic expression
of diseases such as T2D [31,40,43,63]. It is hoped that these more
functionally-speciﬁc phenotypes will exhibit higher genetic signal-to-
noise ratios and speed causal gene identiﬁcation.
2.4. Role of transcriptomics in disease gene identiﬁcation
Transcriptomic analysis, the measurement of gene expression at the
genome-wide level, bridges the gulf between GWAS and physiological
studies (Fig. 1). This is because of the causal relationships between the
genome, the transcriptome and physiological traits. Information nor-
mally ﬂows from the genome to traits of interest via the transcriptome.
Thus, the information residing in genes predisposing to disease is often
differentially expressed as RNA whose concentration can be correlated
with disease-related traits at the physiological level. RecentGWAS stud-
ies have utilized very large population samples, numbering in the tens
of thousands (or even hundreds of thousands) of individuals, yet estab-
lishing causal functional relationships between strongly associated ge-
netic variants and disease remains elusive [4]. Finally, with the advent
of inexpensive and accurate Whole Genome Sequencing (WGS) we
are now on the cusp of a revolution in genomic association studies,
involving genetic datasets of trillions of nucleotide measurements in
combination with multiple physiological measurements [40]. As we
enter this exciting era of genetic research, it may be an appropriate
time to reassess some of the fundamental assumptions underlying
these types of studies.
2.4.1. GWAS vs physiological studies
In striking contrast to recent GWAS results is the remarkable para-
dox that many physiological correlative studies can be well-powered
to detect clinically meaningful and scientiﬁcally generalizable informa-
tionwithmodest sample sizes, often including less than100 individuals,
Fig. 1. Simpliﬁed depiction of the relationship between complex diseases, gene expression
and the genome. BothGWASand transcriptomics seek to deduce the underlying causal ge-
netic relationships between DNA sequence variation and physiological variation. Tran-
script proﬁling analyzes a more direct and greatly simpliﬁed connection between the
genome and complex disease pathology than GWAS. eQTL explicitly analyzes the relation-
ship between DNA sequence variation and gene expression although their extension to
phenotypic analysis can be performed in a similar manner to GWAS. It should be noted
that the relationships in each case, between nucleotides and clinical traits, are correlative
rather than causal. For clarity, the role of active non-coding RNAs is not included although
their role is implicit. Their incompletely understood function would presumably mimic
that of the relatively well-understood protein coding RNAs. Furthermore, their concentra-
tion can be accurately assayed by the same transcriptomic approaches used for protein-
coding RNAs and their similar transcript variants.
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ical traits under investigation are often highly heritable and strongly ge-
netically determined. The majority (N85%) of GWAS signals are located
in non-protein-coding DNA sequences, which collectively comprise
98.5% of the genome, and it is likely that their effect is due to their loca-
tion within or near to regulatory regions which modulate gene expres-
sion. It is also likely that, given the GWAS data and what is currently
known about the regulation of gene expression, multiple variants can
act in concert to regulate the expression of genes which may be in-
volved in key physiological processes, thereby contributing to complex
multifactorial traits/diseases. Transcriptomics provides a method to de-
tect these combinatorial effects by measuring changes in the “genetic
phenotype” (i.e. gene expression) which is functionally intermediate
between the genome sequence and clinically important traits. This bio-
logical gap is further reduced when deep physiological traits are used.
By deﬁnition, these traits lie closer to gene effects than truncated clinical
traits, such as the presence or absence of T2D or obesity, which are com-
monly used in large-scale genetic epidemiological investigations.
2.4.2. Complexity of gene regulation
Gene regulation is a complex multi-layered process involving
numerous proteins and non-coding RNAs which may act at a great dis-
tance from their target gene. Elaborate multi-protein/RNA complexes
must be assembled at the site of regulation. The regulatory mechanism
may be intricate and variable, potentially involving transcript rear-
rangement and mRNA degradation. It is now clear that RNA has a
diverse set of functions and is more than just a messenger between
gene and protein. The mammalian genome is extensively transcribed,
giving rise to thousands of RNA transcripts that are never translated
into proteins. Whether all of these transcripts are functional is currently
debatable, but it is evident that these include families of RNAmolecules
with a regulatory function [34]. The presence of a gene expression
change, which is strongly correlated with relevant physiological chang-
es, in the absence of proximate signiﬁcant GWAS signals, suggests that
relatively distant regulatory variants (and potentially many such vari-
ants) may act in combination to regulate the expression of the targetgene of interest. Such putative gene expression-modulating variants
could potentially act upon target gene expression through the media-
tion of non-protein-coding regulatory RNAs. For example, recent studies
have shown that the expression of many genes is modulated by small
interfering RNAs (siRNAs) and micro-RNAs, e.g. reviews by [10,30],
which do not encode proteins. In addition to microRNAs, many non-
protein-coding RNA species (or “RNA genes”), such as long non-
coding RNAs [42], are transcribed from the genome. Thus, there is
compelling evidence that most of the genome may be transcribed [5,6,
9,19,38,53,58,59,62] and the potential role of non-protein coding RNA
genes in the modulation of protein-coding gene expression remains to
be fully evaluated.
2.4.3. Mode of action of expression regulatory variants
The putative gene-expression-modulating variants could, in princi-
ple, act either through non-coding RNAs or through protein coding
RNAs (via proteins). siRNAs have been shown to operate by binding to
mRNAs, leading to premature mRNA degradation and hence down-
regulation of gene expression [10]. Those proteins known to be involved
in gene expression modulation operate by binding, in a coordinated se-
quential fashion, to enhanceosomes, repressosomes, spliceosomes and
transcriptosomes (for review see [2]). In some cases the regulatory
binding site has been shown to reside far from the putative target
coding sequence, in regions between genes — so-called “gene deserts”
[60,72]. Regulatory binding sites thus integrate the effect of multiple
signals and the effect of individual proteins or RNAs may be multiplica-
tive, by analogy with the ampliﬁcation effects of enzyme regulatory
complexes found in intermediary metabolism and other cellular pro-
cesses. Thus, such putative genetic mechanisms could evade GWAS ap-
proaches designed to detect the association of common or rare variants
with whole-body physiological traits such as the presence or absence of
T2D or obesity. In contrast, transcriptomic techniques measure gene
action directly and can bypass the relatively weak signals of widely
scattered variants within the genome.
2.5. Transcriptomics vs expression quantitative trait loci (eQTL) approaches
The transcriptomic approach uses quantitative gene expression data
and disease-related physiological data tomeasure the direct correlation
between the expression of speciﬁc genes and physiological traits. A re-
lated but conceptually distinct technique measures the correlation of
genetic variants with gene expression. This approach seeks to identify
genomic regions, termed expression quantitative trait loci (eQTL) that
are signiﬁcantly associated with the expression of speciﬁc genes. Thus,
eQTL analysis lies between GWAS and the transcriptomic gene proﬁling
described here. In some respects it may be considered a subtype of
GWAS or an enhanced form of GWAS. However, unlike GWAS, eQTL
analysis tends to require relatively smaller sample sizes. The power for
a given sample size depends on the effect size and it is reasonable to ex-
pect larger genetic effects on transcription than on typical GWAS signals
at the nucleotide level. Thus, sample size requirements may often be
smaller than for GWAS. The number of statistical tests also affects
power, since it determines the false positive error rate. In particular,
the GWAS approach can be problematic because the massive number
of statistical tests, between genetic variants and traits of interest, pre-
sents an enormous potential for false positive results. Whether consid-
ering genotyped variants of several hundred thousand or several
million, including imputed variants, the scale of the problem is vast. In
the case of whole genome sequencing, the problem is at least an order
of magnitude greater. This also presents a problem for eQTL analyses,
which measure the correlation between a similar number of genetic
variants and the expression of transcripts derived from microarray or
RNAseq data. In contrast, multiple testing presents much less of a
problem for transcriptomic analysis, which measures the correlation
between the expression of a comparatively small number of transcripts
and physiological traits of interest.
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genomic variants and physiological traits, they would be expected to
provide support for some GWAS signals. This has been shown empiri-
cally to be the case with many loci for T2D [32]. The great majority of
eQTL identiﬁed to date have been found to act in cis with the gene of
interest rather than in trans [27]. Part of the explanation is the greatly
reduced power to detect trans effects given the enormous multiple
testing issues related to searching for trans eQTL, where most of the 3
billion bp of the genome must be searched, rather than a few hundred
kbp for cis eQTL. The situation may be worse if there are multiple trans
eQTL for a given gene of interest, scattered throughout the genome,
and they act combinatorially and multiplicatively on gene expression
(see Section 2.6 below). This may provide a partial explanation for the
fact thatmanyGWAS signals appear to act in trans. This is because a sig-
niﬁcant fraction of variants cannot, with certainty, be ascribed to act
upon any particular gene because they tend to lie at some distance
from any protein coding sequence and, therefore, their mode of action
is less likely to occur in ciswith respect to genes and potentially more
likely to act in trans. A large proportion (43%) of GWAS hits are located
in intergenic regions [33]. The lack of close proximity of many potential
regulatory variants to coding sequences may in part be due to the fact
that protein coding sequence accounts only for approximately 1.5% of
the genome [35]. Nevertheless this assumption of major trans effects
remains to be validated by rigorous laboratory testing of the effect of
potential regulatory variants on the expression of hypothetical target
genes. In general, such tests are not currently feasible on a large scale.2.6. Gene expression variants and GWAS
In light of the ﬁndings described below (Section 2.7), it is appropri-
ate to consider how and why transcriptomic approaches in small sam-
ples might be capable of identifying complex disease-related genes
which are not apparent using GWAS in very large samples. With regard
to the considerations discussed above for gene identiﬁcation in complex
diseases, we may consider a hypothetical simpliﬁed example. If two
genetic variants exist which act combinatorially and multiplicatively
to strongly regulate the expression of a protein-coding gene “G” but
are located sufﬁciently far apart within the genome, such that the effect
of one or both of the variants is operating “in trans”with respect to gene
“G”, then the association of the two variants with a clinical trait of inter-
estmight be effectively invisible to detection by GWAS, even if both var-
iants could be effectively targeted by speciﬁc oligonucleotides. This is
because the association of each variant with the trait of interest may
be too weak to reach signiﬁcance in association testing even though
the combined andmultiplicative effects of the variants have a strong ef-
fect on the expression of “G”, which in turn inﬂuences the clinical trait.
As previously noted, many GWAS signals are in fact located in non-
exomic regions of the genome and are suspected of being regulatory
variants or of tagging local regulatory sequences which are often non-
canonical, such that a clear functional sequence pattern is difﬁcult to
discern. The situation becomes even more difﬁcult if multiple genetic
variants are involved (see below for a more complex hypothetical ex-
ample) and if many or all of the variants are rare. In such a scenario it
is not unreasonable to propose that association of gene expression
signals with a clinical trait of interest may tend to be stronger than the
association of individual nucleotide variants. As one example of such a
putative mechanism, in a recent study of eQTL contributing to the risk
for coronary artery disease, multiple cis and trans eQTL were identiﬁed,
none ofwhich contributed to thewell-known 9p21.3 risk locus, contain-
ing the “ﬁrst common variant associatedwith coronary artery disease to
yield to the GWAS approach” [12]. Similarly, other studies have shown
the presence ofmultiple trans eQTLwhich “are far from anyGWAS asso-
ciation signals and thus cannot be identiﬁed from theGWAS alone” [32].
This concept ﬁnds additional support in the empirical example de-
scribed below (Section 2.7).2.6.1. Multiple distributed regulatory expression variants
Here we expand upon the theoretical example from the previous
section to a more complex example. Instead of a single regulatory SNP
acting in cis, relative to “G”, the regulatory region might instead, and
more realistically, be hypothetically distributed over perhaps 10 genetic
variants throughout the genome, all acting in trans or in combination
with one or more cis variants. If all 10 variants are involved in the regu-
lation of the “G” transcript, then the potential GWAS signal, that might
otherwise have resided in a single SNP, could be diluted by several
orders of magnitude. This effect would be worsened if truncated high-
level phenotypes are used (e.g. the presence or absence of T2D or
obesity) rather than quantitative deep physiological phenotypes (e.g.
measurements from the oral glucose tolerance test [OGTT] and the
euglycemic hyperinsulinemic clamp). In effect, the use of an intermedi-
ate “genetic phenotype”, gene expression, which is closer to both clini-
cally relevant clinical phenotypes and to the immediate effect of gene
action, further increases the power to detect a clinical effect of gene ac-
tion. This is because the gap between the genomic measurement and
the end-phenotype is greatly decreased and multiple genetic effects
from individual nucleotides converge on a single gene expression phe-
notype. Thus, this “concentrating” effect suggests that the design of
many GWAS experiments may tend to dilute the effects they seek to
elucidate. Another factor enhancing transcriptomic gene identiﬁcation
compared with GWAS is that it isolates and effectively concentrates
gene activity within a speciﬁc tissue and metabolic state, whereas
GWAS necessarily targets the whole genome at all times and states.
2.7. Empirical example of gene discovery by transcriptomics
For illustrative purposes, an example of the transcriptomic approach
described herein is provided by the recent identiﬁcation of a gene, alco-
hol dehydrogenase 1B (ADH1B) with unexpectedly robust gene expres-
sion correlations with multiple deep phenotypes related to T2D.
Detailed results are provided elsewhere [74]. RNA was extracted from
abdominal subcutaneous adipose tissue biopsies from 75 unrelated
non-diabetic Mexican American subjects and genome-wide gene
expression measured on the Illumina HumanHT-12v4 Expression
BeadChip platform, containing 47,324 oligonucleotide probes per
array (derived from RefSeq release 38 and other sources), providing
genome-wide transcriptional coverage of well-characterized genes,
gene candidates, and splice variants. Microarray data were deposited
in the Gene Expression Omnibus (GEO) database under ID GSE64567.
ADH1B expression was inversely correlated with all obesity/insulin re-
sistance (OB/IR) related variables at the tissue and whole body levels:
waist circumference (P=2.8 × 10−9); BMI (P b 0.0001); fasting plasma
insulin (P b 0.001); theHomeostasis Model Assessment of Insulin Resis-
tance, HOMA-IR [50] (P b 0.01); Matsuda Insulin Sensitivity Index [49]
(P b 0.01); β-cell function (Oral Disposition Index [71] across 120 min
of the oral glucose tolerance test (ODI1–120; OGTT) (P = 8.6 × 10−4),
and pre-T2D (impaired glucose tolerance and fasting glucose
during the OGTT) (P = 8.6 × 10−5); and from the euglycemic
hyperinsulinemic clamp technique [18]: total glucose disposal (TGD;
P = 8.6 × 10−10); hepatic glucose production (HGP, P = 8.6 × 10−4);
and free fatty acid IR index (FFA-IRI; P = 1.3 × 10−4). The TGD rate
mainly represents skeletal muscle IR; HGP indicates hepatic IR and
FFA IR indicates adipose IR. As expected, ADH1B protein expression
was decreased with high BMI (P b 0.05, N = 12). Transcription results
for ADH1B were conﬁrmed using quantitative PCR. In summary, de-
creased adipose ADH1B expressionwas associatedwith increased obesi-
ty, whole body IR, liver IR, skeletal muscle IR, adipose tissue IR, and
declining β-cell function. While proof of causality remains to be
established, the ﬁnding of strong consistent correlations across an
array of phenotypes, including several deep physiological phenotypes,
in amodest sample size, increases the prior probability that ADH1B is in-
volved in T2D causation and helps prioritize functional testing. A cau-
tionary note is that some of these physiological traits are, to some
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tween gene expression and these physiological traits could be partially
explained by a reduced number of physiological variables.
In addition to the transcriptomic data obtained from 75 individ-
uals, described above, the ADH1B chromosomal region (4q22) con-
tains GWAS and eQTL data from approximately 69,000 and 1569
individuals, respectively. There were no signiﬁcant GWAS signals
found for association with T2D or related phenotypes (BMI, FPG, FPI)
within at least 200 kb of ADH1B using GWAS SNP data (http://www.
type2diabetesgenetics.org/accessed 4/30/2015). GWAST2D and related
trait data were obtained from a meta-analysis of 69,000 individuals of
European ancestry and covered a total of 3.1 million SNPs. Similarly,
no signiﬁcant eQTL were found for ADH1B in subcutaneous adipose or
any of more than 60 tissues examined (http://www.gtexportal.org/
accessed 4/30/2015). The eQTL data were derived from 1569 RNAseq
samples and contained 8930 signiﬁcant genes. As previously noted,
the lack of localized GWAS and eQTL signals should not be surprising
and provides some support for the proposed model of gene action.
2.7.1. Relative gene expression and tissue availability for transcriptomic
studies
The case for transcriptomic studies is likely to be strengthenedwhen
the gene of interest is highly expressed in the tissue(s) of interest and
can, therefore, provide a potentially stronger and more accurate signal.
According to the EMBL-EBI Expression Atlas (http://www-test.ebi.ac.
uk) using data obtained by microarray assay of 76 normal human tis-
sues (http://BioGPS.org; accessed 5/12/2015), ADH1B was most highly
expressed in adipose tissue, with almost double the expression level
found in the next highest tissue, liver. This ﬁnding was conﬁrmed inde-
pendently by high resolution sequencing of RNA (RNASeq) from 16
human tissues (Illumina Body Map 2.0; accessed 5/12/2015). In the
RNAseq study, ADHIB had substantially higher expression in adipose tis-
sue than in 15 other major tissues examined. Its expression, measured
by RNAseq, was more than 3-fold higher in adipose tissue than in the
next highest tissue, liver. On the other hand, transcriptomic studies in
general are dependent on a limited source of available tissue which
may not always be optimal for the studies' objective. In the present
example, the tissue under study was highly relevant to the disease of
interest and the results were not confounded by the presence of disease
[27].
2.7.2. Some advantages and disadvantages of transcriptomic studies
A key advantage of transcriptomic studies is the ability to detect
causative genes for complex genetic traits due to the proximity of tran-
scripts and phenotypes of interest. A second potential advantage is the
opportunity to measure environmental effects on transcription. Many
transcriptomic studies tend to have case/control designs because of
the difﬁculty of obtaining repeated samples of solid tissue, with the
notable exception of liquid blood samples which can be easily sampled
repeatedly over time. In either case, it is possible to incorporate environ-
mental impacts in the study design, either bymeasuring differential en-
vironmental effects on the study groups or bymeasuring environmental
effects over time andmeasuring the correlation of transcript expression
with environmental exposure.
A limitation of transcriptomic studies is that relevant tissues are
often not available and this difﬁculty is not easily overcome. One prom-
ising approach is the use of induced pluripotent stem cells (iPSCs) de-
rived, for example, from human lymphoblastoid cell lines, although
this too currently has limitations, including the accurate recapitulation
of the target tissue phenotype. Secondly, some important genetic
mechanismsmaynot bemediated through an effect on transcript levels,
or protein levels, and thus may not be detectable by transcriptomic
methods. Such mechanisms include nonsynonymous variants that
may not change RNA or protein levels but may alter protein function.
In this regard, transcriptomic studies can be complementary to genetic
association or whole genome sequencing approaches.2.7.3. Methods for dealing with confounding effects
Transcription is a dynamic process and it can be challenging to
separate confounding effects on gene expression. One commonly used
approach, used in the empirical example described above, in which
disease was not a factor, is to use covariates such as age and sex in mul-
tiple regression analysis. Causalmodels have been developed to address
issues of potential confounding. To take a hypothetical example, we
may observe a correlation between a trait, such as BMI, and a gene's
expression level. The obvious question to ask iswhether this correlation,
regardless of signiﬁcance, is causal or not. If it is causal, then the gene's
expression level will inﬂuence BMI, perhaps with some time lag.
Conversely, there could be reverse causality, with the effect being
reversed, such as the inﬂuence of BMI on a gene's expression level.
More generally, there could be confounding of apparent causality by
other unknown factors. As a hypothetical example, people with higher
BMImight tend to come from socioeconomically deprived backgrounds
that predispose them to eat low quality calorically dense foods more
often, and this diet might also inﬂuence the expression of the
gene(s) in question, even if the gene's expression itself does not
lead to obesity
To disentangle such complex relationships, analytical methods have
been developed, such as mediation analysis [44] and Mendelian ran-
domization [8]. For example, the latter method works because genetic
variants are randomized among us, by the rules of Mendelian inheri-
tance (and some additional assumptions such as non-assortative mat-
ing) and are generally not correlated with possible confounders, such
as someone's socioeconomic status and/or diet. Mendelian
randomization is one of the valuable features that distinguish genetic
epidemiology from most other ﬁelds of epidemiology. In the present
case, if we have a genetic variant that is known to inﬂuence the expres-
sion level of the gene(s) in question, such as a cis-regulatory variant,
then we could test whether this variant is also associated with BMI. If
the gene's expression level causally inﬂuences BMI, then we should be
able to observe an association of the cis-eQTL(s) with BMI aswell. Alter-
natively, if causality is reversed, i.e. BMI inﬂuences gene expression,
then there should be no such association between cis-eQTL(s) and
BMI. This can be carried further by looking at effect sizes, e.g. if a dou-
bling of gene expression correlates with a BMI increase of 10 units,
then a cis-eQTL increasing gene expression by 50% should lead to a
BMI increase of roughly 5 units. In any case, the use of this analytical
strategy requires that we have cis-eQTLs for the gene(s) in question,
or trans eQTLs, but this is much more unlikely. These eQTLs should
come from the same tissue and preferably the same ethnicity.
2.8. Epigenomics, metabolomics and proteomics
In the context of gene expression modulation, three other related
mechanisms should also be considered. (1) epigenomics/chromatin re-
modeling, (2) metabolomics, and (3) proteomics. Epigenomics and
chromatin remodeling refer, respectively, to reversible heritable chang-
es in DNA sequence and changes in chromosome structure. These occur
most commonly via nucleotide and histonemethylation and acetylation
which affect localized chromosomal regions and gene expression
via availability of DNA sequence and potential steric hindrance of
transcriptosome formation. Epigenomics and associated chromosomal
changes must be considered a potential mechanism of action in gene
expression modulation. Epigenomic regulation of gene expression rep-
resents a sub-class of gene expression modulation and is, in principle,
subject to the same kinds of mechanisms and processes as the modula-
tion of RNA concentrations which are measured by transcriptomic pro-
ﬁling. However, aswith GWAS's,whole genome epigenetic changes also
occur at the level of the genome sequence and suffer from a similar dif-
ﬁculty in quantitation at the genome-wide level, and for similar reasons.
Regions of epigenetic changes are inﬂuenced by multiple extrinsic and
intrinsic factors and effectively represent changes at the genomic DNA
level which can be considered analogous to DNA sequence differences
30 C.P. Jenkinson et al. / Genomics Data 8 (2016) 25–36similar to those measured by GWAS but with a greater variability, mak-
ing epidemiological-scale measurements difﬁcult to interpret [1,70]
2.8.1. Complexity of proteomic and metabolomic analysis
Proteomics holds conceptually greater promise as an additional
measure of disease-related genetic change given that it takes the
“genetic phenotype” of RNA expression at least one step closer to the
ultimate clinical phenotype of interest. However, with proteins and
their multiple derivatives an enormous amount of complexity is
introduced and this currently is difﬁcult to resolve [75]. Proteomic and
metabolomic measurements can be exquisitely sensitive to changes in
the concentrations of speciﬁc proteins and metabolites [23]. However,
the task of de novo identiﬁcation of novel protein products andmetabo-
lites is more daunting than that of RNA proﬁling. In comparison,
transcriptomic measurements, which rely on the identiﬁcation of
simple four-nucleotide polymers,whethermeasured by oligonucleotide
arrays or RNA sequencing, are currentlymore amenable to disease gene
identiﬁcation. Thus, genome-wide analyses of very large numbers of
proteins and metabolites, potentially orders of magnitude greater than
RNA species, currently are limited by their inability to simultaneously
identify and measure all possible species encoded by the genome. This
is a technical issue which eventually should be resolved by better
high-throughput high-resolution technology and likely will become a
valuable adjunct to future transcriptomic analysis
It should benoted that there is not a simple 1:1 relationship between
RNA expression and protein expression (including expression of cova-
lently modiﬁed proteins) and this situation is even more complex for
the biosynthesis and use of metabolites. This lack of a simple relation-
ship between RNA expression and protein/metabolite expression
makes interpretation of proteomic and metabolomic data challenging.
In this regard, one lesson that may be drawn from GWAS analyses is
that larger datasetsmay not always provide simple answers inmultifac-
torial diseases where the underlying structure is very complex. For
example, a small proportion of a given protein may become highly
active after phosphorylation and become capable of initiating an expo-
nential intracellular catalytic cascade of activity out of proportion to
the expression of the original non-phosphorylated protein. Thus, the
concentrations of multiple phosphorylated and dephosphorylated
proteins may need to be measured (not to mention the concentrations
of numerous other types of covalently modiﬁed proteins). As with
GWAS, eQTL and transcriptomic correlations, themeasurable proteomic
and metabolomic changes are ultimately encoded within the genome
and transferred via expression of RNAs to eventually interact with the
intracellular and extra-cellular environment.
2.9. Identiﬁcation of accessible chromosomal regions for gene expression
regulation
Newer epigenomics-related approaches can aid the search formean-
ingful non-coding variation by focusing on regions of the genomewhere
regulatory protein complexes are likely to be bound, so-called nuclease
hypersensitivity sites. Such methods are based on the location of
genome-wide sterically accessible open chromatin regions. These
techniques exploit the power of massively parallel next generation
sequencing (NGS) coupled with nuclease digestion to elucidate
the genome-wide location and sequences of gene expression regulatory
sites. Current methods include: (1) the assay for transposase-accessible
chromatin using sequencing (ATAC-seq) [7], which locates putative
sites for all DNA-binding proteins, and (2) chromatin immunoprecipita-
tionwith sequencing (ChIP-seq) [36,37] which locates the binding sites
of known or suspected DNA-binding proteins. We have previously used
ChIP-seq to elucidate genome-wide putative binding sites for the
TCF7L2 transcription factor protein and identiﬁed binding sites for
TCF7L2 regulation of expression of hepatocyte gluconeogenic
genes which appear to be involved in hepatic insulin resistance
[56,57]. Although ATAC-seq and ChIP-seq analyses can be performedindependently of transcriptomic analysis, they represent powerful
synergistic approaches to identify speciﬁc sites of regulation of
gene expression uncovered by transcriptomic studies.
3. Conclusion
In this reviewwe have presented evidence that transcriptomic stud-
ies may offer insights into physiological mechanisms that are not easily
obtained from GWAS or eQTL. We propose that the effects of multiple
genetic variants may “converge” on a single genetic mechanism that
can be assayed by calculating the correlation between the levels of a
particular transcript and phenotype, whereas the effects of individual
genetic variants are comparatively small and difﬁcult to detect. This ap-
proach could allow transcriptomic studies to yield insights from much
smaller sample sizes than have hitherto proven to be necessary for
GWAS, particularly if “deep” phenotypes, that are closer to the physio-
logical traits of interest, are analyzed. We discussed an empirical exam-
ple where highly signiﬁcant associations were detected between the
levels of the transcript for alcohol dehydrogenase 1B, measured in
adipose tissue, and multiple measures of obesity and insulin resistance.
We conclude that transcriptomic analysis can provide a more conve-
nient and direct path bridging the genotype and phenotype than is cur-
rently available using either GWAS or eQTL approaches.
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